Haematopathology - Revision history

Michael at 15:44, 5 March 2017

2017-03-05T15:44:16Z

← Older revision		Revision as of 15:44, 5 March 2017
Line 99:		Line 99:

	===Common markers===		===Common markers===
	*CD3, CD4, CD8, CD5, CD7.		*CD3, CD4, CD8, [[CD5]], CD7.
	*CD19, CD20, FMC7.		*CD19, [[CD20]], FMC7.
	*Kappa, lambda.		*Kappa, lambda.

Michael: /* Cytometry - population cell marker quantification */

2015-10-19T15:36:05Z

Cytometry - population cell marker quantification

← Older revision		Revision as of 15:36, 19 October 2015
Line 120:		Line 120:
	===Abnormal===		===Abnormal===
	See ''[[cytometry]]''.		See ''[[cytometry]]''.

			=Abnormal sign out=
			<pre>
			Lymph Node, Right Posterior Triangle of Neck, Excision:
			- Lymphoid tissue with abnormal architecture, predominantly small cells.
			- Case will be sent to hematopathology for opinion.
			</pre>

	=See also=		=See also=

Michael: /* Haematologic neoplasia */ tweak

2012-02-08T12:31:07Z

Haematologic neoplasia: tweak

← Older revision		Revision as of 12:31, 8 February 2012
Line 30:		Line 30:

	=Haematologic neoplasia=		=Haematologic neoplasia=
	Historically, haematologic neoplasias ~~was~~ split into leukemia (disease of the bone marrow & blood) and lymphoma (discrete ~~mass~~ - usually a lymph ~~node~~). In the modern day this distinction has blurred.		Historically, haematologic neoplasias were split into leukemia (disease of the bone marrow & blood) and lymphoma (disease in discrete masses -- usually lymph nodes). In the modern day, this distinction has blurred.

	==Myelodysplastic syndrome==		==Myelodysplastic syndrome==

Michael: /* Haematologic neoplasia */

2012-02-08T04:34:01Z

Haematologic neoplasia

← Older revision		Revision as of 04:34, 8 February 2012
Line 30:		Line 30:

	=Haematologic neoplasia=		=Haematologic neoplasia=
	Historically, haematologic neoplasias was split into leukemia (disease in the bone marrow & ~~bone~~) and lymphoma (discrete mass; usually a lymph node). In the modern day this distinction has blurred.		Historically, haematologic neoplasias was split into leukemia (disease of the bone marrow & blood) and lymphoma (discrete mass - usually a lymph node). In the modern day this distinction has blurred.

	==Myelodysplastic syndrome==		==Myelodysplastic syndrome==
Line 38:		Line 38:
	==Leukemia==		==Leukemia==
	{{Main\|Leukemia}}		{{Main\|Leukemia}}
			These predominantly have blood/bone marrow involvement.

	==Lymphoma==		==Lymphoma==
	{{main\|Lymphoma}}		{{main\|Lymphoma}}
			These form masses. They typically arise from lymph nodes or aggregates of lymphocytes.

	==Plasma cell lesions==		==Plasma cell lesions==

Michael: more

2012-02-08T04:30:51Z

← Older revision		Revision as of 04:30, 8 February 2012
Line 28:		Line 28:
	**B lymphocytes.		**B lymphocytes.
	**Plasma cells.		**Plasma cells.

			=Haematologic neoplasia=
			Historically, haematologic neoplasias was split into leukemia (disease in the bone marrow & bone) and lymphoma (discrete mass; usually a lymph node). In the modern day this distinction has blurred.

			==Myelodysplastic syndrome==
			{{Main\|Myelodysplastic syndrome}}
			At first approximation, these can be thought of as "pre-leukemia/lymphoma".

			==Leukemia==
			{{Main\|Leukemia}}

			==Lymphoma==
			{{main\|Lymphoma}}

			==Plasma cell lesions==
			{{Main\|Plasma cell neoplasms}}

			==Myeloproliferative neoplasms==
			{{main\|Myeloproliferative neoplasms}}
			This subset of haematopathology includes, among others, polycythemia vera. Historically, these were not classified as neoplasias.

	=Specific diagnoses=		=Specific diagnoses=
Line 68:		Line 88:
	Notes:		Notes:
	*Microvascular occlusion is also seen in [[thrombotic microangiopathies]].		*Microvascular occlusion is also seen in [[thrombotic microangiopathies]].

	~~==Lymphoma==~~
	~~{{main\|Lymphoma}}~~

	~~==Myeloproliferative neoplasms==~~
	~~{{main\|Myeloproliferative neoplasms}}~~
	~~This subset of haematopathology includes, among others, polycythemia vera.~~

	~~==Plasma cell lesions==~~
	~~{{Main\|Plasma cell neoplasms}}~~

	=Cytometry - population cell marker quantification=		=Cytometry - population cell marker quantification=

Michael: change redirect

2012-02-08T04:25:25Z

change redirect

← Older revision		Revision as of 04:25, 8 February 2012
Line 77:		Line 77:

	==Plasma cell lesions==		==Plasma cell lesions==
	~~:See the ''[[lymphoma]]'' article.~~		{{Main\|Plasma cell neoplasms}}

	=Cytometry - population cell marker quantification=		=Cytometry - population cell marker quantification=

Michael: formating

2012-02-08T04:24:04Z

formating

← Older revision		Revision as of 04:24, 8 February 2012
Line 3:		Line 3:
	The lymph node is discussed below; however, details are covered in the ''[[lymph node]]'' article and ''[[lymph node pathology]]'' article.		The lymph node is discussed below; however, details are covered in the ''[[lymph node]]'' article and ''[[lymph node pathology]]'' article.

	==Bone marrow==		=Bone marrow=
	{{main\|Bone marrow}}		{{main\|Bone marrow}}
	Bone marrows are important for understanding haematopathology. They are dealt with in the ''[[bone marrow\|bone]]'' article.		Bone marrows are important for understanding haematopathology. They are dealt with in the ''[[bone marrow\|bone]]'' article.

	==Normal lymph node==		=Normal lymph node=
	{{main\|Lymph node}}		{{main\|Lymph node}}
	{{main\|Lymph node pathology}}		{{main\|Lymph node pathology}}
Line 29:		Line 29:
	**Plasma cells.		**Plasma cells.

			=Specific diagnoses=
	==Hemophagocytic syndrome==		==Hemophagocytic syndrome==
	{{main\|Hemophagocytic syndrome}}		{{main\|Hemophagocytic syndrome}}
Line 78:		Line 79:
	:See the ''[[lymphoma]]'' article.		:See the ''[[lymphoma]]'' article.

	==Cytometry - population cell marker quantification==		=Cytometry - population cell marker quantification=
	{{main\|Cytometry}}		{{main\|Cytometry}}

Line 108:		Line 109:
	See ''[[cytometry]]''.		See ''[[cytometry]]''.

	==See also==		=See also=
	*[[Stomach]].		*[[Stomach]].
	*[[Lymph nodes]].		*[[Lymph nodes]].

	==References==		=References=
	{{reflist\|2}}		{{reflist\|2}}

	[[Category:Haematopathology]]		[[Category:Haematopathology]]

Michael: /* Disseminated intravascular coagulation */ tweak format

2012-01-12T03:50:00Z

Disseminated intravascular coagulation: tweak format

← Older revision		Revision as of 03:50, 12 January 2012
Line 50:		Line 50:

	==Disseminated intravascular coagulation==		==Disseminated intravascular coagulation==
			*Commonly abbreviated ''DIC''.
	===General===		===General===
	*Commonly abbreviated ''DIC''.
	*Usually associated with sepsis or septic shock.<ref>URL: [http://emedicine.medscape.com/article/779097-overview http://emedicine.medscape.com/article/779097-overview]. Accessed on: 23 October 2010.</ref>		*Usually associated with sepsis or septic shock.<ref>URL: [http://emedicine.medscape.com/article/779097-overview http://emedicine.medscape.com/article/779097-overview]. Accessed on: 23 October 2010.</ref>

Michael: /* Bone marrow */ tweak

2012-01-12T03:49:26Z

Bone marrow: tweak

← Older revision		Revision as of 03:49, 12 January 2012
Line 4:		Line 4:

	==Bone marrow==		==Bone marrow==
	{{main\|Bone}}		{{main\|Bone marrow}}
	Bone marrows are important for understanding haematopathology. They are dealt with in the ''[[bone]]'' article.		Bone marrows are important for understanding haematopathology. They are dealt with in the ''[[bone marrow\|bone]]'' article.

	==Normal lymph node==		==Normal lymph node==

Michael: /* Heparin-induced thrombocytopenia */ tweak refs.

2011-05-17T15:10:33Z

Heparin-induced thrombocytopenia: tweak refs.

← Older revision		Revision as of 15:10, 17 May 2011
Line 39:		Line 39:

	==Heparin-induced thrombocytopenia==		==Heparin-induced thrombocytopenia==
	*Thrombocytopenia due to heparin.<ref>[http://emedicine.medscape.com/article/1357846-overview http://emedicine.medscape.com/article/1357846-overview]</ref>		*Thrombocytopenia due to heparin.<ref name=emed_hit>URL: [http://emedicine.medscape.com/article/1357846-overview http://emedicine.medscape.com/article/1357846-overview]. Accessed on: 17 May 2011.</ref>

	Classification:		Classification:
Line 47:		Line 47:
	Diagnosis (simplified):		Diagnosis (simplified):
	*50% decline in platelets - within 4-10 days of starting heparin.		*50% decline in platelets - within 4-10 days of starting heparin.
	*HIT assay - several exist.<ref>[http://emedicine.medscape.com/article/1357846-~~diagnosis~~ http://emedicine.medscape.com/article/1357846-~~diagnosis~~]</ref>		*HIT assay - several exist.<ref name=emed_hit>URL: [http://emedicine.medscape.com/article/1357846-overview http://emedicine.medscape.com/article/1357846-overview]. Accessed on: 17 May 2011.</ref>

	==Disseminated intravascular coagulation==		==Disseminated intravascular coagulation==